Role of angiotensin ii in injuiy-induced neointima formation in rats

Hypertension

Volumn 18, Issue 4, 1991, Pages II-60-II-64

  Osterrieder, Wolfgang ^a   Müller, Rita K M ^a   Powell, Jerry S ^b   Clozel, Jean Paul ^a   Hefti, Fridolin ^a   Baumgartner, Hans R ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin II; Arteriosclerosis; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; CILAZAPRIL; LOSARTAN POTASSIUM;

ANGIOTENSIN BLOOD LEVEL; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BIPHENYL COMPOUNDS; CAROTID ARTERIES; CELL DIVISION; CILAZAPRIL; ENDOTHELIUM, VASCULAR; IMIDAZOLES; LOSARTAN; MALE; PYRIDAZINES; RATS; REGENERATION; TETRAZOLES;

EID: 0026045868     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Peach MJ: Renin-angiotensin system: Biochemistry and mech-anisms of action. Physiol Rev 1977;57:313-370
2. Tigerstedt R, Bergman P: Niere und Kreislauf. Scand Arch Physiol 1898;8:223-271
3. Powell JS, Clozel J-P, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR: Inhibitor of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188
4. Natoff IL, Altwood MR, Eichler DA, Kogler P, Kleinbloesem CH, van Brumrnelen P: Cilazapril. Cardiovasc Drug Rev 1990; 8:1-24
5. ErdSs EG: Angiotensin 1 converting enzyme. Circ Res 1975; 36:247-255
6. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM; Nonpeptide angio-tensin II receptor antagonists: IX. Anti hypertensive activity of DuP 753, an orally active anti hypertensive agent. J Pharmacol Exp Ther 1990;252:726-732
7. Wong PC, Price WA, Qiiu AT, Carini BJ, Duncia JV, Johnson AL, Wexler RR, Timmermans PBMWM: Nonpeptide angio-tensin II receptor antagonists; Studies with EXP9270 and DuP 753. Hypertension 1990;15:823-834
8. Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. Lab Invest 1983;49:327-334
9. Haudenschild CC, Schwartz SM: Endothelial regeneration: II. Restitution of endothelial continuity. Lab Invest 1979;41: 407-418
10. Carini DJ, Dunda JV: European patent 253 310, filing date, July 9, submitted to du Pont de Nemours & Co, Inc, Wil-mington, Del, 1987
11. Cavalli-Sforza L: Grundbegriffe der Biomclrie. Stuttgart, Gustav Fischer Verlag, 1964, pp 46-49
12. Griendling KK, Tsuda T, Berk BC, Alexander RW: Angioten-sin II stimulation of vascular smooth muscle. J Cardiovasc Pharmacol 1989;14(suppl 6):S27-S33
13. Valloton MB, Capponi AM, Rossier MF, Lang U; The mech-anism of vascular smooth muscle cell activation by angiotensin II and vasopressin, in Meyer P, Marche P (eds): Blood Cells and Arteries in Hypertension and Atherosclerosis. New York, Raven Press, Publishers, 1989, pp 35-45
14. Naftilan AJ, Pratt RE, Dzau VJ: Induction of pi ate let-derived growth factor A-chain and c-myc gene expressions by angio-tensin II in cultured rat vascular smooth muscle celts. J Clin Invest 1989;83:1419-1424
15. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, DzauVJ: Angio-tensin II induces c-fos expression in smooth muscle via tran-scriptional control. Hypertension 1989;13:706-711
16. Powell JS, Muller RKM, Rouge M, Kuhn H, Hefti F, Baum-gartner HR: The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme. J Cardiovasc Pharmacol 1990; 16(suppl 4):S42-S49
17. Chang RSL, Lotti VJ: Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpep-tide ligands. Mol Pharmacol 1989;29:347-351
18. Whitebread S, Mele M, Kamber B, de Gasparo M: Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Common 1989;163:284-291
19. Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 1986;314:488-500
20. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesboro JH: Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-1687